Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: An immunohistochemical and molecular biological analysis

Modern Pathology

Volumn 22, Issue 2, 2009, Pages 223-231

  De Vreeze, Ronald S A ^a   De Jong, Daphne ^a   Tielen, Ivon H G ^a   Ruijter, Henrique J ^a   Nederlof, Petra M ^a   Haas, Rick L ^a   Van Coevorden, Frits ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Liposarcoma; Multiplex ligation dependant probe amplification; Myxoid round cell; Retroperitoneal; RT PCR; Well dedifferentiated

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE FUSION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIMB TUMOR; LIPOSARCOMA; MALE; METASTASIS; MOLECULAR BIOLOGY; MOLECULAR MIMICRY; MORPHOLOGY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MYXOSARCOMA; PRIMARY EXTREMITY LIPOSARCOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RETROPERITONEUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROUND CELL LIPOSARCOMA; STAINING;

ADULT; AGED; AGED, 80 AND OVER; CALMODULIN-BINDING PROTEINS; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 12; CYCLIN-DEPENDENT KINASE 4; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MDM2; RETROPERITONEAL NEOPLASMS; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; TERMINOLOGY AS TOPIC; TRANSCRIPTION FACTOR CHOP; TRANSLOCATION, GENETIC;

EID: 59149105193     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.164     Document Type: Article

References (26)

1. Kindblom LG. Lipomatous tumors-how we have reached our present views, what controversies remain and why we still face diagnostic problems: a tribute to Dr Franz Enzinger. Adv Anat Pathol 2006;13:279-285.
2. Downes KA, Goldblum JR, Montgomery EA, et al. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol 2001;14:179-184.
3. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003;238:358-370.
4. Singer S, Socci ND, Ambrosini G, et al. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 2007;67:6626-6636.
5. Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 2000;190:531-536.
6. Hostein I, Pelmus M, Aurias A, et al. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 2004;202:95-102.
7. Italiano A, Cardot N, Dupre F, et al. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the 'missing link' between lipomas and liposarcomas? Int J Cancer 2007;121:308-315.
8. Pitson G, Robinson P, Wilke D, et al. Radiation response: an additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys 2004;60:522-526.
9. Engstrom K, Bergh P, Cederlund CG, et al. Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncol 2007;46:838-845.
10. Jones RL, Fisher C, Al-Muderis O, et al. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer 2005;41:2853-2860.
11. Fletcher CD. Pathology and Genetics Tumours of Soft Tissue and Bone, WHO classification book for tumours of soft tissue and bone, 2002.
12. Vogelstein B, Gillespie D. Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 1979;76:615-619.
13. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.
14. Italiano A, Bianchini L, Keslair F, et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 2008;122:2233-2241.
15. Reifenberger G, Ichimura K, Reifenberger J, et al. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996;56:5141-5145.
16. Simon R, Struckmann K, Schraml P, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002;21:2476-2483.
17. Hameed M. Pathology and genetics of adipocytic tumors. Cytogenet Genome Res 2007;118:138-147.
18. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995;221:185-195.
19. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355-365.
20. Mollabashy A, Virkus WW, Zlotecki RA, et al. Radiation therapy for low-grade soft tissue sarcoma. Clin Orthop Relat Res 2002;397:190-195.
21. Antonescu CR, Elahi A, Healey JH, et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res 2000;6:2788-2793.
22. Estourgie SH, Nielsen GP, Ott MJ. Metastatic patterns of extremity myxoid liposarcoma and their outcome. J Surg Oncol 2002;80:89-93.
23. Antonescu CR, Elahi A, Humphrey M, et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn 2000;2:132-138.
24. Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999;85:85-92.
25. Sirvent N, Coindre JM, Maire G, et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol 2007;31:1476-1489.
26. Shimada S, Ishizawa T, Ishizawa K, et al. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 2006;37:1123-1129.